News
STVN
19.64
-1.21%
-0.24
Stevanato announces collaboration with Aptar Pharma
TipRanks · 9h ago
Aptar Pharma enters collaboration with Stevanato Group
TipRanks · 9h ago
Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update
Seeking Alpha · 11h ago
What Investors Got Wrong About Stevanato Group Before The Drop
Simply Wall St · 12h ago
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Barchart · 15h ago
Weekly Report: what happened at STVN last week (1019-1023)?
Weekly Report · 1d ago
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
Barchart · 10/20 15:30
Why Stevanato Group Bears Were Right Before The Drop
Simply Wall St · 10/20 00:37
Weekly Report: what happened at STVN last week (1012-1016)?
Weekly Report · 10/19 09:44
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 10/14 13:10
Weekly Report: what happened at STVN last week (1005-1009)?
Weekly Report · 10/12 09:47
Stevanato Group is Now Oversold (STVN)
NASDAQ · 10/08 20:41
Stevanato Group initiated with a Hold at Deutsche Bank
TipRanks · 10/07 11:45
Morgan Stanley Gives a Hold Rating to Stevanato Group (STVN)
TipRanks · 10/05 12:38
Weekly Report: what happened at STVN last week (0928-1002)?
Weekly Report · 10/05 09:46
Citi Reaffirms Their Buy Rating on Stevanato Group (STVN)
TipRanks · 10/01 16:45
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
NASDAQ · 10/01 10:02
Top Stevanato Executive Cashes In on Major Stock Move
TipRanks · 10/01 02:01
Morgan Stanley Keeps Their Hold Rating on Stevanato Group (STVN)
TipRanks · 09/28 12:27
Weekly Report: what happened at STVN last week (0921-0925)?
Weekly Report · 09/28 09:44
More
Webull provides a variety of real-time STVN stock news. You can receive the latest news about Stevanato Group S P A through multiple platforms. This information may help you make smarter investment decisions.
About STVN
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.